Concert Pharmaceutic (CNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2011 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||
| Net Income | -11,320 | N/A | N/A |
| Depreciation Amortization | 1,106 | N/A | N/A |
| Accounts receivable | 1,000 | N/A | N/A |
| Accounts payable and accrued liabilities | 403 | N/A | N/A |
| Other Working Capital | -9,548 | N/A | N/A |
| Other Operating Activity | 274 | 0 | 0 |
| Operating Cash Flow | $-18,085 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| Change In Deposits | 23,191 | N/A | N/A |
| PPE Investments | -290 | N/A | N/A |
| Investing Cash Flow | $22,901 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Repayment | -332 | N/A | N/A |
| Common Stock Issued | 15 | N/A | N/A |
| Other Financing Activity | 7,302 | 0 | 0 |
| Financing Cash Flow | $6,985 | $N/A | $N/A |
| Beginning Cash Position | 11,148 | N/A | N/A |
| End Cash Position | 22,949 | N/A | N/A |
| Net Cash Flow | $11,801 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -18,085 | N/A | N/A |
| Capital Expenditure | -290 | N/A | N/A |
| Free Cash Flow | -18,375 | 0 | 0 |